Date | Insider | Price | Amount |
---|---|---|---|
11-7-2023 Insider Buy |
Omega Fund VI, L.P. >10% Owner |
$11.00 CAGR » |
$4,999,995.00 454,545 shares |
11-7-2023 Insider Buy |
Longitude Capital Partners IV, LLC >10% Owner |
$11.00 CAGR » |
$4,999,995.00 454,545 shares |
11-7-2023 Insider Buy |
Invest A/S Lundbeckfond >10% Owner |
$11.00 CAGR » |
$2,499,992.00 227,272 shares |
Also See: Institutional Holders of LXEO
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/08/2023 | |
End date: | 05/03/2024 | |
Start price/share: | $10.64 | |
End price/share: | $12.77 | |
Dividends collected/share: | $0.00 | |
Total return: | 20.02% | |
Annualized Gain: | 41.52% | |
Starting investment: | $10,000.00 | |
Ending investment: | $12,002.00 | |
Years: | 0.48 |
Lexeo Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Lexeo Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding LXEO
Free LXEO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Lexeo Therapeutics Insider Buying occurred are:
Amplify Energy Corp (New) Insider Buying |